Evaluation of Novel Point of Care Coagulation System in Pregnant Women (CCPW)
Status
Conditions
Treatments
Details and patient eligibility
About
In this study the investigators will evaluate a new point of care Quantra Hemostasis Analyzer system to assess coagulation rapidly with ease.
Full description
Unexpected bleeding continues to be an issue that confronts anesthesiologists. Obstetric bleeding spearheads as the leading cause of maternal mortality and morbidity. One of the hurdles that clinicians confront is a lack of point of care coagulation system that can hasten the clinical management strategy in the right direction. Conventional methods take considerable time to obtain results. TEG and ROTEM are currently doing the job however these two modalities requires expertise and proficient training to perform test and interpret results. The level of expertise to run the TEG and ROTEM poses hurdles for providing coagulation around the clock as it requires trained operators. What is currently required for efficient and effective management of obstetric hemorrhage is a point of care coagulation system in the operating room and or labor and delivery suite that is user friendly, easy and quick to perform. In this study the investigators will evaluate a new point of care Quantra Hemostasis Analyzer system to assess coagulation rapidly with ease.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Pregnant woman at 37-41 weeks gestation
Exclusion criteria
- Hypertension
- Preeclampsia
- Gestational diabetes
- Preexisting coagulopathy
- History of deep vein thrombosis (DVT)
- Medications that impair coagulation
- History of pulmonary embolism or thrombosis
- Women in active labor receiving intravenous fluids or oxytocin
Trial design
13 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal